國家衛生研究院 NHRI:Item 3990099045/7698
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 854066      Online Users : 1448
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/7698


    Title: Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
    Authors: Liu, SC;Tsang, NM;Chiang, WC;Chang, KP;Hsueh, C;Liang, Y;Juang, JL;Chow, KPN;Chang, YS
    Contributors: Institute of Molecular and Genomic Medicine
    Abstract: Radioresistance of EBV-associated nasopharyngeal carcinoma (NPC) is associated with poor prognosis for patients with this form of cancer. Here, we found that NPC patients had increased serum levels of leukemia inhibitory factor (LIF) and that higher LIP levels correlated with local tumor recurrence. Furthermore, in vitro studies with NPC cells and in vivo xenograft mouse studies demonstrated that LIF critically contributes to NPC tumor growth and radioresistance. Using these model systems, we found that LIP treatment activated the mTORC1/p70S6K signaling pathway, enhanced tumor growth, inhibited DNA damage responses, and enhanced radioresistance. Treatment with either soluble LIF receptor (sLIFR), a LIP antagonist, or the mTOR inhibitor rapamycin reversed LIP-mediated effects, resulting in growth arrest and increased sensitivity to gamma irradiation. Immunohistochemical (IHC) analyses of human NPC biopsies revealed that LIF and LIFR were overexpressed in tumor cells and that LIP expression correlated with the presence of the activated p-p70S6K. Finally, we found that the EBV-encoded protein latent membrane protein 1 (LMP1) enhances LIP production. Together, our findings indicate that LIP promotes NPC tumorigenesis and suggest that serum LIP levels may predict local recurrence and radiosensitivity in NPC patients.
    Date: 2013-12-02
    Relation: Journal of Clinical Investigation. 2013 Dec 2;123(12):5269-5283.
    Link to: http://dx.doi.org/10.1172/jci63428ds1
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0021-9738&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000327826100031
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84890110205
    Appears in Collections:[Jyh-Lyh Juang] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    PB2013122402.pdf7543KbAdobe PDF702View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback